Skip to main content
Arvee Laboratories (India) Limited logo

Arvee Laboratories (India) Limited — Investor Relations & Filings

Ticker · ARVEE ISIN · INE006Z01016 LEI · 33580075Q2EAWYCO4C50 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 280 across all filing types
Latest filing 2025-11-04 Regulatory Filings
Country IN India
Listing National Stock Exchange of India ARVEE

About Arvee Laboratories (India) Limited

http://arveelabs.com/

Arvee Laboratories (India) Limited specializes in the manufacturing and export of specialty chemicals and pharmaceutical intermediates. The company focuses on the production of high-quality chemical compounds, including Dimethyl 5-Sulfoisophthalate Sodium Salt (DMSIP), 5-Sulfoisophthalic Acid Monosodium Salt, and various other aromatic intermediates. These products serve as critical components in the textile, polymer, and pharmaceutical sectors. Arvee Laboratories emphasizes research and development to enhance its chemical synthesis processes and maintain international quality standards. Its operations involve complex chemical reactions such as sulfonation, esterification, and reduction, catering to a diverse global clientele requiring specialized chemical solutions for industrial applications.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-11-04 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notification to the stock exchange about an upcoming Board Meeting where the company will declare its unaudited financial results for the quarter ended 30th September 2025. It is an intimation or announcement of a future event (declaration of quarterly financial results), not the actual financial report or results themselves. The document is short (1476 characters) and serves as a formal notice rather than containing substantive financial data or analysis. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about the scheduling of a board meeting and financial results declaration.
2025-11-04 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is titled 'Proceedings of the 13th Annual General Meeting' and details the date, time, venue, and summary of the AGM including business conducted, voting procedures, and resolutions passed. It explicitly states it is a gist of proceedings of the AGM and not the minutes or full report. It also mentions that voting results will be submitted separately. The document is about the AGM event itself and the summary of what transpired, which fits the definition of AGM Information (AGM-R). The document length is about 5177 characters, which is consistent with a detailed AGM proceedings summary rather than a full annual report or voting results announcement. Therefore, the best classification is AGM Information (AGM-R).
2025-09-24 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the National Stock Exchange of India Limited, informing about the closure of the trading window for insiders due to the upcoming declaration of financial results for the period ended 30th September 2025. It references compliance with SEBI (Prohibition of Insider Trading) Regulations and is signed by the Company Secretary and Compliance Officer. The content is an announcement related to insider trading restrictions and does not contain any financial data, report, or detailed analysis. The document length is short (1479 characters) and serves as a regulatory notification rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other specific categories.
2025-09-22 English
Shareholders meeting
Annual Report Classification · 100% confidence The document is from Arvee Laboratories (India) Limited and includes a detailed Annual Report for the financial year ended 31st March 2025. It contains the Notice of the 13th Annual General Meeting (AGM), Directors' Report, Auditor's Report, Balance Sheet, and other comprehensive sections typical of a full Annual Report. The document length is 15,000 characters, indicating it is a full report rather than a brief announcement. The text explicitly states it is the Annual Report for 2024-2025 and includes substantive financial statements and governance information. Therefore, this document fits the definition of an Annual Report (10-K). FY 2025
2025-08-30 English
Appointment
Board/Management Information Classification · 100% confidence The document is a formal announcement addressed to the National Stock Exchange of India regarding the appointment of a new director, Mr. Saurin Ajitbhai Gandhi, as an Additional Director of Arvee Laboratories (India) Limited. It includes details such as the date of appointment, brief profile, and confirmation that the individual is not debarred from holding office. The document references compliance with SEBI regulations and provides no financial data or report content. This fits the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-08-12 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.